ITP team, RevBio, Advances Dental Implant Stabilization Trials•ITP team, RevBio, Advances Dental Implant Stabilization Trials•Please join us @ the 2025 Translational Resource Center Networking Exchange: April 22-23, 2025 | Boston, MA•Congratulations to our Interdisciplinary Translational Project team at GreenMark Biomedical Inc on their recent publication in the Journal of the American Dental Association - Foundational Science!•ITP RevBio Receives FDA approval for a first in-human Clinical Trial!•ITP PI, Dr. Isabelle Lombaert wins the 2023 University of Michigan Medical School’s Frankel Innovation Initiative Award!•RevBio Awarded a $3.4 Million NIH Grant•MPWRM Resource Center and DOCTRC were highlighted in the keynote talk at NIDCR's 75th anniversary event, NIDCR at 75: Celebrating the Past, Charting the Future•RevBio Receives ISO 13485 Certification for its Quality Management System!•GreenMark Biomedical Launches CrystLCare™ Biorestorative, Fluoride-Free!

Intellectual Property Strategy

Translational Resource Center’s Intellectual Property Strategy experts use their academic commercial translation expertise to unearth, evaluate, analyze, and broadly identify IP opportunities related to DOC technologies. Our process will assist investigators in thoroughly understanding their technology and patent novelty, enabling their university’s technology transfer office to maximize protection of research innovations.

Contact translationalrc@umich.edu for specific guidance and/or more information about the IP services available.